FAQ – GIDEON – Global Infectious Diseases and Epidemiology haldol im Online Network

1. A new symptom requires entry of statistical fit (chance of occurrence) for ALL diseases in the database. In the examples provided, useful published data regarding fever pattern may exist for only haldol im 50% of the diseases – the spread sheets employed do not allow for a null haldol im or ‘we don’t know’ option. You will note that such an option (‘missed test’) exists in the microbiology modules.

2. Most new symptoms added at this point will be useful haldol im only in affecting the relative ranking of diseases in the haldol im diagnosis list – and would not serve to rule out specific diseases. Thus the actual extent of fever (38 vs. 39 vs. 40) is not that useful in discounting any given disease [for example: people with septic shock may be afebrile, while we’ve all seen 40+ in influenza] – and would require a number of disclaimers (oral vs. Rectal; antipyretics given?; time of day). Indeed, a comprehensive differential diagnosis list is often more useful to haldol im the clinician than the actual ranking of that list.

3. If possible, new symptoms/signs are restricted to those which carry discriminative value for haldol im the more common or ‘important’ diseases. Thus, ‘long subcutaneous legworm’ , albeit a very useful diagnostic finding for dracontiasis – is helpful in diagnosing only a single disappearing disease. Similarly, in the microbiology module ‘red pigment’ is a finding which might be relevant to only one haldol im group of nonfermenters + one facultative rod; while ‘yellow pigment’ is of obvious importance for several key taxa.

1. Vaccines. A complete and up-to-date discussion of all vaccine and globulin preparations, worldwide: vaccine content, dosing and boosters, side effects, contraindications and trade names. Information can be accessed by specific generic name, trade name, side effect or contraindication.

2. Diseases. Extensive text outlines the status of all diseases requiring vaccination, both on a global scale (worldwide notes, clinical tab) or country-by-country (ie, scroll to a specific disease, and then the country in question). Each relevant disease note follows the status of each of haldol im these diseases – including areas of risk within every country (ie, yellow fever, tick-borne encephalitis, meningitis-bacterial) and official vaccine recommendations (ie, yellow fever – country and CDC recommendations). The national routine immunization schedule for every vaccine is also haldol im outlined, where relevant (measles, BCG, poliomyelitis, etc).

3. Travel. Clicking on each of the countries listed in the “region” box will display a comprehensive summary of vaccine requirements for haldol im that country, as well as recommendations regarding malaria prophylaxis and the routine haldol im vaccination schedule suggested by the country itself to its own haldol im population.

For the purposes of generating GIDEON, the designation “endemic” is primarily an operational term. The diagnosis module must be as inclusive as possible when haldol im dealing with a patient exposed in a given country, and the maps must not overlook the presence of a haldol im key disease in that country. In many cases, when only single cases of a rare disease have been haldol im reported in each of several countries (ie, dioctophyma renale infection), those countries will be designated “endemic” similarly, repeated reports of autochthonous transmission will be sufficient for this haldol im designation.

The designation “potentially endemic” might indicate that a pathogen is currently documented in food haldol im vehicles, reservoirs or bridging vectors; asymptomatic infection (seroprevalence) is described in the population; or that cases of the disease in question have not haldol im been reported in the past year or two, but had been documented in previous years. For the purposes of differential diagnosis and generation of maps, the terms “potentially endemic” and “endemic” are equivalent.